Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 2, 2015, Pages E214-E222

  Rao, J U ^a   Engelke, U F H ^a   Sweep, F C G J ^a   Pacak, K ^b   Kusters, B ^a,d   Goudswaard, A G ^a   Hermus, A R M M ^a   Mensenkamp, A R ^a   Eisenhofer, G ^c   Qin, N ^c   Richter, S ^c   Kunst, H P M ^a   Timmers, H J L M ^a   Wevers, R A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE; N ACETYLASPARTIC ACID; NEUROFIBROMIN; PROTEIN RET; VON HIPPEL LINDAU PROTEIN;

ADULT; ARTICLE; CARCINOGENESIS; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MIDDLE AGED; MOLECULAR PATHOLOGY; NF 1 GENE; ONCOGENE; OUTCOME ASSESSMENT; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RET GENE; SDHAF 2 GENE; SDHB GENE; SDHD GENE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TUMOR DIFFERENTIATION; VHL GENE; ADOLESCENT; ADRENAL TUMOR; GENETICS; GERMLINE MUTATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; YOUNG ADULT;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; FEMALE; GENOTYPE; GERM-LINE MUTATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; YOUNG ADULT;

EID: 84927566634     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2138     Document Type: Article

References (21)

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005; 366: 665-675.
2. Welander J, Söderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011; 18: R253-R276.
3. Lorenzo FR, Yang C, Ng Tang Fui M, et al. A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J Mol Med. 2013; 91: 507-512.
4. Castro-Vega LJ, Buffet A, De Cubas AA, et al. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet. 2014; 23: 2440-2446.
5. Favier J, Brière JJ, Burnichon N, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PloS One. 2009; 4: e7094.
6. Rao JU, Engelke UF, Rodenburg RJ, et al. Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma. Clin Cancer Res. 2013; 19: 3787-3795.
7. Rapizzi E, Ercolino T, Canu L, et al. Mitochondrial function and content in pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers. Endocr Relat Cancer. 2012; 19: 261-269.
8. Weljie AM, Jirik FR. Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect. Int J Biochem Cell Biol. 2011; 43: 981-989.
9. Wishart DS Advances in metabolite identification. Bioanalysis. 2011; 3: 1769-1782.
10. Weljie AM, Bondareva A, Zang P, Jirik FR. (1)H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts inabreast cancer modelsystem. J Biomol NMR. 2011; 49: 185-193.
11. Engelke UF, Kremer B, Kluijtmans LA, et al. NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism. NMR Biomed. 2006; 19: 271-278.
12. 1H-NMR of cerebrospinal fluid. Clin Chem. 1995; 41: 744-751.
13. Pillwein K, Chiba P, Knoflach A, et al. Purine metabolism of human glioblastoma in vivo. Cancer Res. 1990; 50: 1576-1579.
14. Göttle M, Burhenne H, Sutcliffe D, Jinnah HA. Purine metabolism during neuronal differentiation: The relevance of purine synthesis and recycling. J Neurochem. 2013; 127: 805-818.
15. Patel TB, Clark JB. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J. 1979; 184: 539-546.
16. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, Clark JB. Inhibition of N-acetylaspartate production: Implications for 1H MRS studies in vivo. Neuroreport. 1996; 7: 1397-1400.
17. Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology. 1993; 43: 2484-2490.
18. Ziegler A, von Kienlin M, Décorps M, Rémy C. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res. 2001; 61: 5595-5600.
19. van der Zijden JP, van Eijsden P, de Graaf RA, Dijkhuizen RM. 1H/13C MR spectroscopic imaging of regionally specific metabolic alterations after experimental stroke. Brain. 2008; 131: 2209-2219.
20. Imperiale A, Moussallieh FM, Sebag F, et al. A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas. PloS One. 2013; 8: e80539.
21. 1H-NMR spectros-copy of body fluids: Inborn errors of purine and pyrimidine metabolism. Clin Chem. 1999; 45: 539-548.